CareNet Clinical Research Operations Co.

What CareNet Clinical Research Operations Co. does

CareNet Clinical Research Operations Co. (CCRO) is a Japan-based clinical development and clinical research support services provider serving pharmaceutical companies, medical device manufacturers, and medical institutions. The company was formed on April 1, 2026 through the merger of Craice Co., Ltd. and Satt Co., Ltd., both of which had previously operated as CareNet Group subsidiaries; Craice provided clinical development support including monitoring and physician-initiated trials aimed at addressing Japan's drug lag/loss problem, while Satt provided clinical research support and evidence generation for medical institutions.

CCRO operates as a member of CareNet Group, a Japanese healthcare conglomerate whose physician platform and digital technology assets the new entity leverages for client reach. The combined service offering spans monitoring, physician-led trial support, and one-stop evidence creation, positioning CCRO as a mid-market Japanese CRO that serves three distinct verticals — pharmaceutical sponsors, medical device companies, and medical institutions — through direct enterprise field sales rather than a self-serve or transactional channel.

The business model is per-project professional services for enterprise clients; pricing is not publicly disclosed. Headcount, revenue, customer logos, and certifications are not disclosed in available sources, the technology stack is not specified, and the company maintains a single headquarters in Minato-ku, Tokyo with no disclosed geographic expansion beyond Japan. AI/ML capabilities, patents, and external funding are not mentioned in the source material.

Name

CareNet Clinical Research Operations Co.

Legal name

ケアネットクリinicalリサーチオペレーションズ株式会社

Website

https://ccro.co.jp

Company type

Private

Founded year

2026

Operating status

Operating

Short description

CareNet Clinical Research Operations Co. (CCRO) is a Tokyo-based CRO formed in April 2026 from the merger of Craice and Satt, providing clinical development and clinical research support services to pharmaceutical companies, medical device manufacturers, and medical institutions in Japan as a member of CareNet Group.

Ownership category

akta.pro rank

Product category

Clinical Research Services (Contract Research Organization)

NAICS

Scientific Research and Development Services (5417)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Clinical CROs (Phase I–IV) (HLAGAAAA)

akta.pro secondary industries

Clinical Trial Monitoring Support (On-site/Remote) (HLAGACAG), Clinical Quality Assurance (GCP QA, TMF/QMS oversight) (HLAGAKAI), Clinical Research Support (CRC/CTA) (EDAOAJAO)

Keywords

• Clinical development services
• Clinical research support
• Pharmaceutical trial monitoring
• Medical evidence generation
• Contract research organization

Headquarters

HQ city

Tokyo

HQ country

Japan

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Clinical Development Support Services: Professional services for clinical development including monitoring and physician-initiated trials support for pharmaceutical companies and medical device manufacturers.
2. Clinical Research Support Services: Comprehensive clinical research support services including evidence generation for medical institutions and healthcare organizations.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Core offering

CareNet Clinical Research Operations Inc. (CCRO) provides clinical development support and clinical research support services to pharmaceutical companies, medical device manufacturers, and medical institutions in Japan. Its offering covers clinical trial monitoring, physician-initiated clinical trials support, and one-stop clinical research support for evidence generation, helping clients resolve drug lag/loss issues and produce high-quality clinical evidence.

Product overview

CareNet Clinical Research Operations Inc. operates as a unified company formed from the merger of two specialized entities: クレイズ株式会社 (Crace) providing clinical development support services from monitoring to physician-led trials, and Satt株式会社 providing clinical research support services with one-stop evidence creation capabilities. The new combined entity leverages CareNet Group's physician platform and digital technology to deliver high-value services to pharmaceutical companies, medical device companies, and medical institutions.

Differentiator

Problem solved

Functional benefit

Products and services

• Clinical Development Support Services (Craice Co., Ltd.) Professional clinical development support services including clinical trial monitoring and physician-initiated clinical trial support, focused on resolving drug lag/loss issues for pharmaceutical companies. Clinical development professionals deliver high-quality clinical development solutions.
• Clinical Research Support Services (Satt Co., Ltd.) One-stop clinical research support services for high-quality evidence creation. Clinical research professionals support medical activities for medical institutions by leveraging clinical research capabilities to create new value in medical practice.

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• CareNet GroupcoreStrategic or Co-development Partner · 1 April 2026CareNet Clinical Research Operations Inc. is a member of CareNet Group. The company integrates clinical development support from Crace Co., Ltd. and clinical research support from Satt Co., Ltd., leveraging CareNet Group's physician platform and digital technology to deliver high-value-added services to pharmaceutical companies, medical device manufacturers, and medical institutions.

Scale indicators2 records

Recent moves5 records

Expansion highlights3 records

Broad incumbents

• Parexel International: Global CRO offering clinical development, regulatory, and biopharmaceutical services across geographies, including Japan operations. Directly overlaps with CCRO's monitoring, physician-initiated trials, and evidence-generation services.
• Syneos Health: Global clinical and commercial solutions provider with Asia-Pacific operations including Japan. Comparable in clinical monitoring and full-service development support that CCRO's pharma-vertical clients require.
• IQVIA: Global CRO and life-science services giant with a substantial Japan presence. Competes head-to-head for Japanese pharma trials and offers the international delivery footprint that CCRO lacks.
• ICON plc: Global CRO providing clinical research services across all phases. Relevant comparator for the trial-monitoring and clinical-operations work that the Craice-side of CCRO performs, particularly for global sponsors running programs in Japan.

Direct peers

• CMIC Group: Japan's largest domestic CRO offering clinical trial monitoring, site management, and pharma services. Most direct competitor within Japan for both pharma-sponsored and investigator-initiated trial work that CCRO covers via its Craice heritage.
• EPS Holdings: Major Japanese CRO/SMO providing clinical development, monitoring, and site management across pharma and medical devices. Closely comparable in vertical coverage and domestic-only Japan footprint to CCRO.
• LINICAL Co., Ltd. Japan-headquartered CRO with global trial operations covering oncology and other therapeutic areas. Competes directly for the same Japanese pharma and medical-device clients that CCRO targets, with overlapping monitoring and trial management services.

Others

• Medidata Solutions (Dassault Systèmes): Clinical trial technology platform provider used by CROs and sponsors. Adjacent rather than directly competing; relevant as the technology backbone that CCRO leverages via CareNet Group's digital platform for trial operations and data capture.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks6 records

Key highlights5 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CareNet Clinical Research Operations Co.